COX-2 and beyond: approaches to prostaglandin inhibition in human disease
Top Cited Papers
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (11) , 879-890
- https://doi.org/10.1038/nrd1225
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agentsClinical Therapeutics, 2003
- Prostaglandin transportProstaglandins & Other Lipid Mediators, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.Circulation, 1985
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980